Edit |   |
---|---|
Antigenic Specificity | CD19, Human (Tafasitamab biosimilar) |
Clone | Tafasitamab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1-G2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD19 Recombinant Antibody (Tafasitamab). Tafasitamab, sold under the brand name Monjuvi, is a medication used in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). |
Immunogen | n/a |
Other Names | Anti-CD19 Recombinant Antibody, Research Grade Tafasitamab, Anti-Human CD19 Recombinant Antibody(Tafasitamab), MOR-00208, MOR-208, XENP-5574, Antibody Drug Analogues, Monoclonal Antibody, YR1352, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1422527-84-1 |
Catalog # | YR1352 |
Price | please inquire |
Order / More Info | CD19, Human (Tafasitamab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |